List of works - Martha Nason

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

scientific article published on 26 September 2008

A Survey on Including Risks in the New "Key Information" Section of an Informed Consent Form.

scientific article published in December 2018

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

scientific article (publication date: 15 December 2007)

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial ⬇️

scientific article published on March 11, 2011

A boundary-optimized rejection region test for the two-sample binomial problem

scientific article

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate ⬇️

scientific article published on August 19, 2010

A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection

scientific article

A proof of concept for structure-based vaccine design targeting RSV in humans

scientific article published on 01 August 2019

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

scientific article published on 27 April 2016

Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak

scientific article published on 17 September 2017

Adaptive viral load monitoring frequency to facilitate differentiated care: a modeling study from Rakai, Uganda

scientific article published on 18 September 2019

An Augmented Probit Model for Missing Predictable Covariates in Quantal Bioassay with Small Sample Size ⬇️

scientific article published on January 6, 2011

Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization

scientific article

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

scientific article published on 01 July 2019

Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis

scientific article

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

scientific article published on 14 December 2020

Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid

scientific article published on 21 December 2016

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

scientific article published on 21 February 2017

Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene

scientific article published on July 2008

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts

scientific article

Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables

scientific article

Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia

scientific article published on 11 January 2020

Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis)

scientific article published on 15 May 2020

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

scientific article published on 22 October 2020

Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV

scientific article published on 26 October 2020

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

scientific article

Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus

scientific article published in January 2014

Conditioning in 2 x 2 tables

scientific article published on 23 May 2008

Considerations for the design of vaccine efficacy trials during public health emergencies

scientific article published on 14 February 2018

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

scientific article published on 31 May 2012

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice.

scientific article

Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

scientific article published in June 2016

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks

scientific article published on 01 April 2020

DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial ⬇️

scientific article published on April 8, 2013

Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy

scientific article published in August 2006

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination ⬇️

scientific article published on April 4, 2012

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

scientific article

Design and analysis of crossover trials for absorbing binary endpoints

article by Martha Nason & Dean Follmann published 1 September 2010 in Biometrics

Design of vaccine efficacy trials during public health emergencies

scientific article published on 01 July 2019

Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization

scientific article published in January 2010

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

scientific article published on 01 June 2020

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

scientific article

Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies

scientific article published on 24 June 2020

Early immunologic and virologic predictors of clinical HIV-1 disease progression.

scientific article

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

scientific article published on 2 September 2015

Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients

scientific article

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

scientific article published on 13 August 2014

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo

scientific article

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

scientific article published on 28 July 2020

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

scientific article published on 15 October 2008

Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies

scientific article published on 31 July 2018

HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies

scientific article published on 28 January 2015

HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes

scientific article published on 18 January 2012

Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial

scientific article

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

scientific article

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

scientific article published on 11 June 2020

Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease

scientific article published on 28 August 2018

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

scientific article

Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment

scientific article published on March 2016

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

scientific article published on 18 December 2013

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

scientific article published on 14 January 2016

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques

scientific article

Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains

scientific article published on 01 February 2020

Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses

scientific article published on 10 March 2017

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

scientific article

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

scientific article

Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay

scientific article

No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study

scientific article

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011).

scientific article published on 22 October 2009

P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults

scientific article published on 22 October 2009

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen

article

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

scientific article

Patterns of signs, symptoms and laboratory values associated with Zika, dengue and undefined acute illnesses in a dengue endemic region: secondary analysis of a prospective cohort study in southern México

scientific article published on 25 June 2020

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control

scientific article

Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

scientific article published on October 2017

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

scientific article published on 29 September 2021

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

scientific article published on 07 March 2007

Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)

scientific article

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them

scientific article published on 02 December 2020

Plasma levels of soluble CD14 independently predict mortality in HIV infection

scientific article

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

scientific article

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

scientific article (publication date: 2 February 2010)

Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia

scientific article published on 05 September 2019

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

scientific article (publication date: 9 May 2016)

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

scientific article

Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection

scientific article published on 06 April 2009

Rapid development of a DNA vaccine for Zika virus

scientific article

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

scientific article (publication date: 13 August 2010)

Reduced Frequency of Cells Latently Infected with Replication-Competent HIV-1 in Virally Suppressed Individuals Living in Rakai, Uganda

scientific article published on 23 May 2017

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities

scientific article published on 19 January 2009

Response to letter by Antonio Martín Andrés on “A boundary-optimized rejection region test for the two-sample binomial problem”

scientific article published on 01 June 2018

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

scientific article published on 11 June 2020

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

scientific article published on 05 August 2020

SEARCHPATTOOL: a new method for mining the most specific frequent patterns for binding sites with application to prokaryotic DNA sequences

scientific article

SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets ⬇️

scientific article published on January 7, 2011

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

scientific article

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

article by Martin R Gaudinski et al published 2 March 2019 in The Lancet

Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses

scientific article published on 18 September 2008

Statistics and logistics: Design of Ebola vaccine trials in West Africa

scientific article published on 14 January 2016

Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

scientific article

Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge Model

Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials

scientific article published on 08 May 2019

The mechanistic analysis of founder virus data in challenge models

scientific article published on 10 June 2021

Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire

scientific article published on 12 March 2013

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication

scientific article published on 24 August 2018

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

scientific article published on 9 July 2014

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

scientific article

Variable Importance in Tree-based Models ⬇️

doctoral thesis by Martha Nason, University of Washington, 2003

Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection

scientific article

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

scholarly article by Kizzmekia Corbett et al published 20 August 2021 in Nature Immunology

List of works by Martha Nason

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

A Survey on Including Risks in the New "Key Information" Section of an Informed Consent Form.

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial ⬇️

A boundary-optimized rejection region test for the two-sample binomial problem

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate ⬇️

A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection

A proof of concept for structure-based vaccine design targeting RSV in humans

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak

Adaptive viral load monitoring frequency to facilitate differentiated care: a modeling study from Rakai, Uganda

An Augmented Probit Model for Missing Predictable Covariates in Quantal Bioassay with Small Sample Size ⬇️

Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts

Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables

Cardiovascular Biomarker Profile on Antiretroviral Therapy Is Not Influenced by History of an IRIS Event in People With HIV and Suppressed Viremia

Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis)

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with HIV

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus

Conditioning in 2 x 2 tables

Considerations for the design of vaccine efficacy trials during public health emergencies

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice

Correction: Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice.

Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks

DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial ⬇️

Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination ⬇️

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

Design and analysis of crossover trials for absorbing binary endpoints

Design of vaccine efficacy trials during public health emergencies

Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies

Early immunologic and virologic predictors of clinical HIV-1 disease progression.

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies

HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies

HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes

Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques

Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains

Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay

No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011).

P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

Patterns of signs, symptoms and laboratory values associated with Zika, dengue and undefined acute illnesses in a dengue endemic region: secondary analysis of a prospective cohort study in southern México

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control

Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)